United States Federal Circuit

ResetAA Font size: Print

Novartis AG v. Noven Pharms., Inc., 2016-1678

In an appeal of inter partes review of pharmaceutical patents, the Patent Trial and Appeal Board's findings that various claims of the Patents-in-Suit would have been obvious over the prior art, is affirmed where: 1) prior judicial opinions did not bind the PTAB; and 2) substantial evidence supports the PTAB's underlying factual findings that the asserted claims would have been unpatentable as obvious.

Appellate Information

  • Argued
  • Submitted
  • Decided
  • Published 2017/04/04




  • United States Federal Circuit


FindLaw Career Center

      Post a Job  |  View More Jobs

    View More